Company intelligence / Profile preview

Cafoli Pharmaceuticals

Lagos, Lagos, Nigeria

Ownership: Private
Development stage: Other

Overview

Cafoli Pharmaceuticals is a Nigerian pharmaceutical company dedicated to the production, marketing, and distribution of high-quality, affordable healthcare products. Based in Lagos, the company operates primarily in the West African market, offering a diverse portfolio of branded generic medications. Their product range spans several critical therapeutic areas, including pain management, anti-infectives, and anti-malarial treatments. Cafoli is recognized for its commitment to improving public health through the consistent supply of essential medicines such as Cafol-500 and C-Flox.

Therapeutic areas: NeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Cafoli Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cafoli Pharmaceuticals.

Explore the full profile